Ticker Details
INmune Bio Inc. Common stock
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotechnology
Market Cap:	$34.03M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 3.83%
Avg Daily Range (30 D):	$0.05 | 3.57%
Avg Daily Range (90 D):	$0.06 | 3.76%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.41M
Avg Daily Volume (90 D):	.4M

Trade Size
Avg Trade Size (Sh.):	134
Avg Trade Size (Sh.) (30 D):	142
Avg Trade Size (Sh.) (90 D):	159

Institutional Trades
Total Institutional Trades:	26
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$2M
Avg Institutional Trade (90 D):	$2M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$2M
Avg Closing Trade (90 D):	$2M
Avg Closing Volume:	185.19K

News

Mar 19, 2026 @ 12:00 PM INmune Bio’s MINDFuL Trial Featured at AD/P... Source: Inmune Bio Inc.

Dec 5, 2025 @ 12:00 PM Peer Reviewed Study Highlights Therapeutic Potenti... Source: Dr. Nikita M. Patel

Jul 31, 2025 @ 11:00 AM INmune Bio Inc. to Report Second Quarter 2025 Fina... Source: Inmune Bio Inc.

Jun 26, 2025 @ 8:00 PM INmune Bio Inc. to Announce Top Line Results from ... Source: Inmune Bio Inc.

Jul 19, 2024 @ 9:53 PM Inmune Bio re-elects directors, ratifies auditor -... Source: Natashya Angelica

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.86	$-.18	$-1.86
Diluted EPS	$-1.86	$-.18	$-1.86
Revenue	$.05M	$M	$.05M
Gross Profit
Net Income / Loss	$-45.93M	$-5.26M	$-45.93M
Operating Income / Loss	$-47.38M	$-5.47M	$-47.38M
Cost of Revenue
Net Cash Flow	$.16M	$-6.65M	$.16M
PE Ratio